The Orbera gastric balloon is a non-surgical, temporary weight-loss device placed in the stomach to reduce food intake. The balloon is inflated and left in place for six months. During that time, patients follow a strict diet and exercise regimen to lose weight. It’s a popular choice for patients who want to avoid invasive surgery.

Wegovy (semaglutide) is a medication that helps with weight loss by mimicking a hormone that regulates appetite. It is prescribed to individuals with obesity or those with weight-related health problems. In the UK, Wegovy has been approved for NHS use for patients who meet certain criteria, providing a non-surgical option for those seeking medical weight-loss assistance.

Gastric RNY, or Roux-en-Y gastric bypass, remains one of the most effective surgical options for treating obesity. By reducing the size of the stomach and bypassing a portion of the intestines, patients experience a significant reduction in hunger and an inability to eat large meals. Gastric RNY can lead to rapid weight loss and improvement or resolution of obesity-related conditions such as type 2 diabetes, sleep apnea, and hypertension.

Roux-en-Y (RNY) gastric bypass is a type of weight-loss surgery in which the stomach is divided into a small upper pouch and a larger lower "remnant" portion. The small intestine is rearranged to connect to both. This reduces the stomach's capacity and alters how the body absorbs calories and nutrients, making it one of the most effective bariatric surgeries for long-term weight loss. Patients can expect significant weight loss, but the procedure is more complex than other forms of bariatric surgery, requiring... +More

Patients typically need a Body Mass Index (BMI) of 35 or higher, with obesity-related health conditions, or a BMI of 40 or more to qualify for gastric sleeve surgery. This surgery, known as Vertical Sleeve Gastrectomy (VSG), involves removing about 80% of the stomach to reduce food intake and is one of the most popular bariatric procedures.

A "belly doctor" typically refers to a gastroenterologist, a specialist who treats conditions affecting the stomach and digestive system. Patients see belly doctors for issues like ulcers, acid reflux, irritable bowel syndrome (IBS), and chronic stomach pain. Bariatric patients often consult gastroenterologists for pre- and post-surgery care to ensure their digestive systems are functioning well after surgeries like gastric bypass.

Weight loss help encompasses a wide range of tools, including bariatric surgery, medication (such as appetite suppressants), diet plans, and exercise regimens. For individuals struggling with obesity, working with healthcare professionals like dietitians, bariatric surgeons, and therapists can provide tailored support to achieve long-term weight loss.

Patients who undergo sleeve gastrectomy in Antalya often share impressive before-and-after photos that showcase significant weight loss. Most patients lose 60-70% of their excess body weight within the first year after surgery. Antalya is well-known for delivering high-quality results at a fraction of the cost found in the UK, US, or other Western countries, making it a popular choice for those considering the surgery.

Semaglutide is a weight-loss medication that mimics a hormone regulating appetite and food intake. In the UK, it is marketed under the brand names Ozempic (for diabetes) and Wegovy (for obesity). It is prescribed to individuals struggling with weight management, often in conjunction with diet and exercise.

In the UK, lap band surgery (also known as adjustable gastric banding) is available both privately and through the NHS in some cases. The surgery involves placing an adjustable band around the upper part of the stomach, reducing food intake. Private lap band surgery in the UK typically costs between £5,000 and £8,000.

Common gastrology symptoms include stomach pain, bloating, indigestion, nausea, vomiting, and changes in bowel habits. These symptoms may indicate a range of conditions from gastritis to more serious issues like ulcers or gastrointestinal cancers.

Gastric RNY, or Roux-en-Y gastric bypass, remains one of the most effective surgical options for treating obesity. By reducing the size of the stomach and bypassing a portion of the intestines, patients experience a significant reduction in hunger and an inability to eat large meals. Gastric RNY can lead to rapid weight loss and improvement or resolution of obesity-related conditions such as type 2 diabetes, sleep apnea, and hypertension.

Non-surgical gastric sleeve alternatives, like Endoscopic Sleeve Gastroplasty (ESG), are gaining popularity in Turkey. ESG is a minimally invasive procedure where a doctor uses an endoscope to place sutures in the stomach, reducing its size without surgery. This procedure has a quicker recovery time and fewer risks compared to traditional surgery, making it an attractive option for those unable to undergo more invasive procedures.

The cost of Roux-en-Y (RNY) gastric bypass surgery varies widely depending on the country, hospital, and insurance coverage. In the U.S., it typically ranges between $20,000 and $30,000. In the UK, the procedure may be covered by the NHS if the patient meets specific criteria, or it can be done privately for £8,000 to £15,000.

Gastro refers to gastrointestinal conditions broadly, while gastritis specifically refers to inflammation of the stomach lining. Gastro disorders can include a range of conditions affecting the entire digestive tract, whereas gastritis is a localized condition of the stomach.

Gastric band tablets are not a recognized treatment, but the term might refer to weight-loss medications that mimic the effects of a gastric band by suppressing appetite or blocking fat absorption. Medications like Orlistat or appetite suppressants are sometimes used in combination with bariatric procedures.